Could secondary prevention of coronary heart disease be more effective?

Could secondary prevention of coronary heart disease be more effective?

Beta-adrenoblockers (BAB) in secondary prevention of coronary heart disease (CHD) are not always effective, due to non-achieved target heart rate (HR). The reasons for that could include medication intolerance, baseline bradycardia (HR<55 bpm), II-III Stage atrio-ventricular blocks, and acute...

Full description

Bibliographic Details
Main Author:	V. I. Makolkin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ишемическая болезнь сердца вторичная профилактика β-адреноблокаторы ивабрадин
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2022

Similar Items

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction
by: R. G. Oganov, et al.
Published: (2005-06-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey
by: N. V. Pogosova, et al.
Published: (2020-12-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

Physical activity assessment in coronary heart disease patients: questionnaire ODA-23+
by: V. B. Krasnitskyi, et al.
Published: (1970-01-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

Arterial hypertension and coronary heart disease treatment compliance – a key factor in cardiovascular mortality reduction
by: G. V. Pogosova, et al.
Published: (2007-02-01)

Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01)

Relevant problems of participation and education of patients in cardiac rehabilitation and secondary prevention programs
by: M. G. Bubnova
Published: (2020-12-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Could heart rate be regarded as cardiovascular disease risk factor?
by: V. I. Makolkin, et al.
Published: (2006-12-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

Implementing principles of coronary heart disease secondary prevention into real-world clinical practice
by: D. M. Aronov, et al.
Published: (2007-02-01)

MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION
by: Frans Van de Werf, et al.
Published: (2016-01-01)

Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa
by: E G Volkova
Published: (2005-06-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

HIGH RISK STRATEGY EFFICACY IN PROGNOSIS OF PRIMARY ONSET OF ISCHEMIC HEART
by: I. S. Skopets, et al.
Published: (2014-12-01)

New perspectives in coronary heart disease management
by: V. I. Makolkin
Published: (2005-02-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)

Dose-dependent effect of statins on the change in the content of individual fatty acids of blood serum and their complexes of men and women with secondary prevention of chronic coronary heart disease
by: M. Yu. Kotlovsky, et al.
Published: (2018-03-01)

The specific features of the diagnosis and treatment of coronary heart disease in rheumatoid arthritis (Results of the authors’ studies)
by: Natalya Anatolyevna Khramtsova, et al.
Published: (2012-06-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

IVABRADINE INFLUENCE ON SYSTOLIC AND DIASTOLIC FUNCTION OF HEART VENTRICLES IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER PRIMARY REVASCULARIZATION
by: N. V. Drobotya, et al.
Published: (2014-10-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Relationship between coronary artery calcification and osteopenic syndrome in men with coronary heart disease
by: T. A. Raskina, et al.
Published: (2016-06-01)

CARDIOCYTOPROTECTION PERSPECTIVES WITH ISCHEMIC PRECONDITIONING: HYPOXIA-INDUCED FACTOR 1 — POSSIBLE MOLECULAR MECHANISM AND TARGET FOR PHARMACOTHERAPY
by: A. V. Lyubimov, et al.
Published: (2017-12-01)

CEREBROVASCULAR PATHOLOGY IN PATIENTS WITH CORONARY HEART DISEASE (NEROIMAGING RESULTS)
by: Irina Danilovna Syrova, et al.
Published: (2023-09-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Epidemiology of acute coronary heart disease in the Russian Federation: experience and perspectives
by: S. S. Yakushin, et al.
Published: (2009-08-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

Respiratory function in patients with coronary heart disease in combination with chronic obstructive pulmonary disease
by: А. С. Клинкова, et al.
Published: (2015-10-01)

Structural and functional base of coronary heart disease typology
by: A. S. Dimov, et al.
Published: (1970-01-01)

Modern aspects of angina treatment in arterial hypertension patients: emphasizing endothelial function role
by: L. L. Kirichenko, et al.
Published: (2008-04-01)